DormandyJARutherfordRB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg.2000;31:S1–S296.
2.
HirschATHaskalZJHertzerNR. ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic): A Collaborative Report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients with Peripheral Arterial Disease)–Summary of Recommendations. J Vasc Interv Radiol.2006;17:1383–1398.
3.
BremHTomic-CanicM. Cellular and molecular basis of wound healing in diabetes. J Clin Invest.2007;117:1219–1222.
TsetisDBelliAM. The role of infrapopliteal angioplasty. Br J Radiol.2004;77:1007–1015.
7.
SiablisDKarnabatidisDKatsanosK. Sirolimus-eluting versus bare stents after suboptimal infrapopliteal angioplasty for critical limb ischemia: enduring 1-year angiographic and clinical benefit. J Endovasc Ther.2007; 14:241–250.
8.
KandarpaKBeckerGJHuninkMG. Transcatheter interventions for the treatment of peripheral atherosclerotic lesions: part I. J Vasc Interv Radiol.2001;12:683–695.
9.
RomitiMAlbersMBrochado-NetoFC. Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J Vasc Surg.2008;47:975–981.
Biondi-ZoccaiGGSangiorgiGLotrionteM. Infragenicular stent implantation for below-the-knee atherosclerotic disease: clinical evidence from an international collaborative meta-analysis on 640 patients. J Endovasc Ther.2009;16:251–260.
12.
FeiringAJKrahnMNelsonL. Preventing leg amputations in critical limb ischemia with below-the-knee drug-eluting stents: the PaRADISE (PReventing Amputations using Drug eluting StEnts) trial. J Am Coll Cardiol.2010;55:1580–1589.
13.
SiablisDKarnabatidisDKatsanosK. Infrapopliteal application of sirolimus-eluting versus bare metal stents for critical limb ischemia: analysis of long-term angiographic and clinical outcome. J Vasc Interv Radiol.2009;20:1141–1150.
14.
RastanASchwarzwälderUNooryE. Primary use of sirolimus-eluting stents for angioplasty in the infrapopliteal arteries. J Endovasc Ther.2010;17:480–487.
15.
PopmaJJTopolEJ. Factors influencing restenosis after coronary angioplasty. Am J Med.1990;88:16N–24N.
16.
KarasSPSantoianECGravanisMB. Restenosis following coronary angioplasty. Clin Cardiol.1991;14:791–801.
17.
DaviesMGSaadWEPedenEK. Impact of runoff on superficial femoral artery endoluminal interventions for rest pain and tissue loss. J Vasc Surg.2008;48:619–626.
18.
SalapuraVBlincAKozakM. Infrapopliteal run-off and the outcome of femoropopliteal percutaneous transluminal angioplasty. Vasa.2010;39:159–168.
19.
PeregrinJHKoznarBKovacJ. PTA of infrapopliteal arteries: long-term clinical follow-up and analysis of factors influencing clinical outcome. Cardiovasc Intervent Radiol.2010May11. [Epub ahead of print].
